Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.

Medicine & Life Sciences

• Circulating Tumor DNA 100%
• Liquid Biopsy 97%
• Technology 45%
• Neoplasms 15%
• Karyotyping 8%
• Cell-Free Nucleic Acids 8%
• Whole Genome Sequencing 8%
• Mutation 7%
• Body Fluids 7%
• Physiological Phenomena 7%
• Nucleic Acids 6%
• High-Throughput Nucleotide Sequencing 6%
• Immunity 5%
• Clone Cells 5%
• Polymerase Chain Reaction 4%
• Therapeutics 1%

Engineering & Materials Science

• Biopsy 90%
• Tumors 70%
• Liquids 46%
• Electrochemical sensors 9%
• Nucleic acids 9%
• Coagulation 8%
• Body fluids 8%
• Genomics 6%
• Blood 5%
• Aging of materials 5%
• Monitoring 3%

Chemical Compounds

• Mutation 58%
• Liquid 37%
• Coagulation 35%
• Nucleic Acid 29%